HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.

AbstractBACKGROUND & AIMS:
Visceral hypersensitivity plays a major role in the pathophysiology of inflammatory bowel syndrome (IBS). Opioid kappa receptors on afferent nerves may modulate it and may be the target of new IBS treatments. The aim of this study was to evaluate the effects of fedotozine, a potent and selective kappa agonist, on responses to colonic distention and colonic compliance in patients with IBS.
METHODS:
Fourteen patients with IBS (Rome criteria; 50 +/- 12 years; 6 men and 8 women) were included in a randomized double-blind, crossover trial comparing the effect of an intravenous infusion of 100 mg fedotozine or saline on sensory thresholds elicited by left colon phasic distention (4-mm Hg steps for 5 minutes) up to a sensation of abdominal pain. Colonic compliance was compared by the slope of the pressure-volume curves built on placebo and on fedotozine.
RESULTS:
In the fedotozine group, thresholds of first perception (28.7 +/- 5.9 mm Hg) and pain (34.7 +/- 5.5 mm Hg) were significantly greater than with placebo (23.3 +/- 4.5 and 29.0 +/- 3.5 mm Hg, respectively; P = 0.0078). Colonic compliance was 9. 20 +/- 3.87 mL. mm Hg-1 with placebo and 8.73 +/- 3.18 mL. mm Hg-1 with fedotozine (not significant).
CONCLUSIONS:
Fedotozine increases thresholds of perception of colonic distention in patients with IBS without modifying colonic compliance. Fedotozine seems capable of reversing visceral hypersensitivity observed in these patients and could have some beneficial action on their symptoms.
AuthorsM Delvaux, D Louvel, E Lagier, B Scherrer, J L Abitbol, J Frexinos
JournalGastroenterology (Gastroenterology) Vol. 116 Issue 1 Pg. 38-45 (Jan 1999) ISSN: 0016-5085 [Print] United States
PMID9869600 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzyl Compounds
  • Propylamines
  • Receptors, Opioid, kappa
  • fedotozine
Topics
  • Adult
  • Benzyl Compounds (administration & dosage, therapeutic use)
  • Colon (drug effects, physiopathology)
  • Colonic Diseases, Functional (drug therapy, physiopathology)
  • Cross-Over Studies
  • Double-Blind Method
  • Eating
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Manometry
  • Middle Aged
  • Pain Threshold (drug effects)
  • Propylamines (administration & dosage, therapeutic use)
  • Receptors, Opioid, kappa (agonists)
  • Sensory Thresholds (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: